Taliban Administration Announces New Drug Pricing Plan to Curb High Costs
The Deputy Head of the Food and Drug Department at the Taliban Ministry of Public Health has announced that a new bill to regulate drug prices will soon be implemented nationwide, aiming to prevent the sale of medicines at excessively high prices.
Maulvi Hamdullah Zahed stated that with the enforcement of this bill, drug prices will be closely monitored to prevent unreasonable increases. In recent years, many residents in various provinces have complained about the high cost of medicine and the lack of effective oversight.
He also warned that companies and factories involved in importing counterfeit or low-quality medicines from abroad will be blacklisted. According to him, the Taliban administration will take serious action against the distribution of substandard drugs.
The deputy head further added that the import of medicines from Pakistan has been halted due to what he described as “the harmful nature of certain products,” claiming that credible evidence supports this decision.
Health experts emphasize that transparent oversight, standardized testing, and public access to quality medicines are fundamental needs of the country’s healthcare system—an objective that requires effective management and clear accountability from responsible institutions.
